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Abstract
Background: Mice that lack acyl CoA:diacylglycerol acyltransferase (Dgat1-/- mice) are reported
to have a reduced body fat content and improved glucose tolerance and insulin sensitivity. Studies
so far have focussed on male null mice fed a high fat diet and there are few data on heterozygotes.
We compared male and female Dgat1-/-, Dgat1+/- and Dgat1+/+ C57Bl/6 mice fed on either standard
chow or a high fat diet.
Results: Body fat content was lower in the Dgat1-/- than the Dgat1+/+ mice in both experiments;
lean body mass was higher in male Dgat1-/- than Dgat1+/+ mice fed on the high fat diet. Energy intake
and expenditure were higher in male Dgat1-/- than Dgat1+/+ mice; these differences were less
marked or absent in females. The body fat content of female Dgat1+/- mice was intermediate
between that of Dgat1-/- and Dgat1+/+ mice, whereas male Dgat1+/- mice were similar to or fatter
than Dgat1+/+ mice. Glucose tolerance was improved and plasma insulin reduced in Dgat1-/- mice
fed on the high fat diet, but not on the chow diet. Both male and female Dgat1+/- mice had similar
glucose tolerance to Dgat1+/+ mice.
Conclusion: These results suggest that although ablation of DGAT1 improves glucose tolerance
by preventing obesity in mice fed on a high fat diet, it does not improve glucose tolerance in mice
fed on a low fat diet.
Background
The final step of triglyceride synthesis in mammals is cat-
alysed by the enzymes acyl CoA:diacylglycerol acyltrans-
ferase 1 and 2 (DGAT1 and DGAT2), which have
dissimilar amino acid sequences. Both enzymes are
widely expressed and are highly expressed in adipose tis-
sue and liver [1]. Previous reports have described resist-
ance to diet-induced obesity [2] and amelioration of
obesity due to the Ay, but not the Lepob or LepRdb, mutation
[3] in DGAT1-deficient (Dgat1-/-) mice. Resistance to
obesity was associated with increased reductions in body
weight and food intake in response to peripherally but not
centrally administered leptin [3,4]. Food intake relative to
body weight was either unchanged [2] or raised [3,4], and
energy expenditure relative to body weight was raised [2],
suggesting that the primary effect of DGAT1 deficiency is
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on the energy expenditure side of the energy balance
equation. Increased locomotor activity and brown adi-
pose tissue thermogenesis have been invoked to account
for increased energy expenditure [2,3,5]. It appears, how-
ever, that fat oxidation is increased in liver as well as skel-
etal muscle and brown adipose tissue because the
concentration of diacylglycerol was reduced in the liver of
Dgat1-/- mice [3]. This finding is paradoxical since one
might expect the concentration of diacylglycerol – the
substrate of DGAT1 – to be raised in Dgat1-/- mice, but it
can be rationalised if fat oxidation is somehow increased.
Stimulation of fatty acid oxidation is usually associated
with improved insulin sensitivity and glucose tolerance,
possibly because the concentrations of lipid metabolites
that inhibit the insulin signalling pathway (e.g. long chain
fatty acyl CoA, diacylglycerol, ceramide) are reduced [6].
Moreover, in the longer term, insulin sensitivity will
improve due to the reduced plasma non-esterified fatty
acid concentration and altered adipokine profile associ-
ated with decreased adipocyte lipid stores. Therefore it is
not surprising that Dgat1-/-  C57Bl/6 mice have been
reported to show improved insulin sensitivity [3,7,8].
However, overexpression of DGAT1 in adipose tissue of
C57Bl/6 mice was associated with obesity but not with
impaired glucose disposal [9]. By contrast, overexpression
of DGAT1 in adipose tissue of FVB mice, a strain known
to be resistant to diet-induced obesity, was not associated
with obesity, but was associated with insulin resistance
[10]. These results support the view that an increased
capacity for triacylglycerol synthesis is not detrimental to
insulin sensitivity provided it is confined to adipocytes
and newly formed adipocytes can accommodate any
excess triacylglycerol.
We found in a pilot experiment [11] that, in contrast to a
previous report [2] glucose tolerance and insulin toler-
ance were actually worse, and fasting plasma insulin was
raised in Dgat1-/- compared to wildtype mice fed on a
chow (low fat) diet. The knockout mice appeared to bor-
der on a state of 'functional lipodystrophy'. The wildtype
mice used in this pilot experiment were age-matched to
the Dgat1-/- mice rather than being littermates, raising the
possibility that a minor variation in genetic background
could have been responsible for the difference. We have
therefore now compared Dgat1-/- and littermate Dgat1+/+
mice fed on both chow and high fat diets with respect to
glucose homeostasis and energy balance. While we do not
repeat the finding of impaired glucose tolerance, we do
find that it is only on the high fat diet that glucose toler-
ance is improved in the Dgat1-/- mice. Since there are lim-
ited data on the phenotype of heterozygote (Dgat1+/-)
mice [1], these were included in the study to give some
perspective on how much inhibition of DGAT1 might be
required to treat obesity and type 2 diabetes. We also com-
pared the effects of knockout of the Dgat1 gene in both
male and female mice, whereas previous studies have
focussed on males.
Results
When the mice were fed throughout on a chow diet, ter-
minal body weight and lean body mass (at 20 weeks of
age) were not significantly affected by genotype (Figs. 1A,
C). However, the female Dgat1-/- mice had a higher body
weight than either the Dgat1+/- or the Dgat1+/+ mice at 9
weeks of age (21.5 ± 0.3, 20.0 ± 0.4, 19.3 ± 0.3 g respec-
tively; n = 12; P < 0.05). When the mice were fed on the
high fat diet, the male Dgat1-/- mice had a markedly higher
lean body mass compared to the Dgat1+/+ mice (Fig. 1D),
but this was not reflected in terminal body weight (Fig.
1B) because body fat content was reduced (Fig. 1F).
This reduction in body fat content in Dgat1-/- mice when
the mice were fed on a high fat diet was larger (7 g in
males and 8 g in females, compared to Dgat1+/+ mice; Fig.
1F) than when the mice were fed on chow (2 g in females,
and 0.7 g, which was not statistically significant, in males;
Fig. 1E). The Dgat1+/- mice did not have significantly
altered body fat content compared to the Dgat1+/+ mice on
either diet, but in females their body fat content was inter-
mediate between that of the Dgat1+/+ and Dgat1-/- mice,
whereas in males the Dgat1+/- mice fed on the chow diet
actually tended to have a higher body fat content than the
Dgat1+/+ mice (P = 0.046 by Fisher least significant differ-
ence test, but not significant after Bonferroni correction
for four tests). Adiposity was reflected in terminal fat pad
weights and plasma leptin levels (Table 1). The male
Dgat1+/- mice had significantly higher fat pad weights and
leptin levels than Dgat1+/+ mice even after Bonferroni cor-
rection.
In the chow diet experiment, food intake from 9 to 20
weeks of age was higher in both male and female Dgat1-/-
than in Dgat1+/+ mice (Fig. 2A). Energy expenditure at 12
weeks of age was raised in the male Dgat1-/- mice (Fig. 2B).
Energy expenditure was not significantly raised in the
female Dgat1-/- mice, but there was a trend (P = 0.087 by
Fisher test) to an increase that paralleled the food intake
data. In the high fat diet experiment, food intake from 12
to 30 weeks of age was higher in male Dgat1-/- than Dgat1+/
+ mice, but there was no difference in food intake between
the female genotypes (Fig. 2C). Food intake and energy
expenditure in the Dgat1+/- mice were no different from in
the Dgat1+/+ mice.
An unexpected finding was that in the chow diet experi-
ment, glucose tolerance was, by contrast with a previous
report [2], very similar in mice of the three different geno-
types (Fig. 3A). However, in the high fat diet experiment,
the area under the glucose tolerance curve was, asLipids in Health and Disease 2007, 6:2 http://www.lipidworld.com/content/6/1/2
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Final body weight (A, B), lean body mass (C, D) and fat mass (E, F) in Dgat1+/+ (+/+), Dgat1+/- (+/-) and Dgat1-/-(-/-) mice fed on  a chow diet (A, C, E) or a high fat diet (B, D, F) Figure 1
Final body weight (A, B), lean body mass (C, D) and fat mass (E, F) in Dgat1+/+ (+/+), Dgat1+/- (+/-) and Dgat1-/-(-/-) mice fed on 
a chow diet (A, C, E) or a high fat diet (B, D, F). Results are means of 12 values ± S.E., except that there were 6 female Dgat1-/
- mice fed on the high fat diet. **P < 0.01; ***P < 0.001, compared to Dgat1+/+ mice of the same sex.
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expected, lower in the male Dgat1-/- than in the male
Dgat1+/- or Dgat1+/+ mice, and in both male and female
Dgat1-/-  mice the blood glucose concentration was
reduced at the later time-points (Figs. 3C, D). The fasting
plasma insulin concentration was similarly unaffected by
genotype in mice fed on the chow diet (Fig. 4A), but lower
in the Dgat1-/- than the Dgat1+/- or Dgat1+/+ mice fed on the
high fat diet (Fig. 4B). The plasma insulin concentration
was also lower in the female Dgat1-/- than the Dgat1+/- or
Dgat1+/+ mice 30 min after the glucose load (Fig. 4C).
Discussion
Our results are consistent with a previous report [2] in
showing that Dgat1-/- mice have a lower body fat content
than Dgat1+/+ mice and are resistant to diet-induced obes-
ity. They also agree that energy turnover is increased in
male  Dgat1-/-  mice, although this was less evident in
female Dgat1-/- mice. They differ, however, from previous
reports that show [2] or imply [7] that glucose tolerance is
improved in Dgat1-/- mice fed on a chow diet.
Body fat content was higher in the Dgat1+/+ mice fed on
the high fat diet compared with the same mice fed on the
chow diet, but it was similar in Dgat1-/- mice fed on the
high fat and chow diets. Consequently, the effect of abla-
tion of the gene was greater in mice fed on the high fat
diet. The effect of ablation of the Dgat1 gene was as appar-
ent in female as in male mice, which have been the focus
of previous studies.
Why the absence of an enzyme involved in triacylglycerol
synthesis should increase fat oxidation and energy
expenditure is not known. One study suggested that a fac-
tor released in increased amounts from the adipose tissue
of Dgat1-/- mice could play a role [7], but it seems unlikely
that this factor is adiponectin [1,12]. Plasma adiponectin
was decreased in male Dgat1-/- mice in our pilot experi-
ment [11], which is also inconsistent with this hypothesis.
Increased locomotor activity in Dgat1-/- mice raises the
possibility that ablation of DGAT1 in the brain raises
energy expenditure in the periphery. Thus hypothalamic
lipid metabolites are known to affect energy expenditure
[13]. However, overexpression of DGAT1 in adipose tis-
sue alters body composition [9,10], and overexpression of
DGAT1 in rat isolated islets of Langerhans increases trig-
lyceride synthesis [14]. Therefore, at least in adipose tissue
and islets, DGAT1 can have a direct effect on triglyceride
storage.
An unexpected finding that may in part account for
increased energy expenditure in male Dgat1-/- mice was
that lean body mass, which has more influence on energy
expenditure than fat mass [15-17], was increased in male
Dgat1-/- mice fed on the high fat diet. Lean body mass was
not raised significantly in the particular group – male
Dgat1-/- mice – where energy expenditure was significantly
raised in the present study, but energy expenditure was
measured at 12 weeks of age and body composition at 20
weeks of age. Other workers have not observed increased
lean body mass in Dgat1-/- mice [12], although a trend to
increased percentage protein content in Dgat1-/- mice fed
on a chow diet has been reported [2].
Our finding that glucose tolerance was not improved in
Dgat1-/- mice fed on a chow diet compares with studies on
the overexpression of DGAT1. This did not result in
impaired glucose disposal in a strain of mice that was able
to respond with increased adipose tissue fat stores [18],
but did cause insulin resistance in a strain that was unable
to accommodate extra lipid in adipocytes [10]. In the cur-
rent study, in contrast to our pilot experiment [11], abla-
tion of DGAT1 did not impair glucose tolerance, but
nevertheless, inhibition of lipid synthesis in animals that
have a low capacity for adipocyte triglyceride accumula-
tion may risk exacerbating insulin sensitivity. In this
regard, it is interesting that lipodystrophic animals and
humans are characterised by insulin resistance [19] and a
recent report suggests that lipodystrophic humans have an
increased lean body mass [20], a feature displayed by
male Dgat1-/- mice in the current work.
Table 1: Terminal plasma leptin and perigenital fat pad weights
Males Females
+/+ +/- -/- +/+ +/- -/-
Chow diet:
Leptin (ng/ml) 2.2 ± 1.8 4.4 ± 1.8*** 1.5 ± 0.4 5.5 ± 3.7 4.2 ± 2.4 1.9 ± 0.2
Fat pad weight (g) 0.50 ± 0.07 0.78 ± 0.11* 0.32 ± 0.03*** 0.70 ± 0.08 0.56 ± 0.08 0.31 ± 0.05***
High fat diet:
Leptin (ng/ml) 16.3 ± 2.1 16.0 ± 2.4 1.2 ± 0.3*** 21.1 ± 1.5 19.6 ± 2.2 2.8 ± 0.3***
Fat pad weight (g) 1.57 ± 0.13 1.52 ± 0.7 0.32 ± 0.04*** 1.67 ± 0.18 1.31 ± 0.15 0.48 ± 0.14***
Values are means ± S.E. of 10 to 12 values, except that there were 5 values for plasma leptin and 6 for fat pad weight for the female Dgat1-/- mice 
fed on the high fat diet.
* P < 0.05; *** P < 0.001 compared to wildtype mice of the same sex.Lipids in Health and Disease 2007, 6:2 http://www.lipidworld.com/content/6/1/2
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Food intake (A) and energy expenditure (B) in Dgat1+/+ (+/+), Dgat1+/- (+/-) and Dgat1-/-(-/-) mice fed on a chow diet, and food  intake (C) in mice fed on a high fat diet Figure 2
Food intake (A) and energy expenditure (B) in Dgat1+/+ (+/+), Dgat1+/- (+/-) and Dgat1-/-(-/-) mice fed on a chow diet, and food 
intake (C) in mice fed on a high fat diet. Results are means of 4 values ± S.E., except that there were two values for food intake 
(C) for the female Dgat1-/- mice fed on the high fat diet (and hence the top of the error bar corresponds to the higher of these 
two values, which differed by only 1.6%). *P < 0.05; **P < 0.01; ***P < 0.001 compared to Dgat1+/+ mice of the same sex.
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There were no significant differences between the hetero-
zygote (Dgat1+/-) and Dgat1+/+ mice, except for the surpris-
ing finding of increased fat pad weights and leptin
concentration in the male Dgat1+/- mice fed on chow. This
contrasts with a previous report that male heterozygote
mice had a total fat pad weight intermediate between
Dgat1-/- and Dgat1+/+ mice [1]. Female heterozygote mice,
by contrast, did have an intermediate phenotype in terms
of fat mass (Fig. 2). Perhaps compensatory mechanisms,
such as increased DGAT2 activity, were more pronounced
in males than in females. Glucose tolerance was very sim-
ilar in heterozygote and wildtype mice. This suggests that
to treat type 2 diabetes with an inhibitor of DGAT1 it may
be necessary to inhibit activity markedly. The activities of
DGAT1 in the wildtype and heterozygote mice were not
compared, however.
Conclusion
Dgat1-/- mice had a lower body fat content than wildtype
mice and males had an increased lean body mass when
they were fed on a high fat diet. Improved glucose toler-
ance and reduced plasma insulin levels were apparent
only when the mice were fed on a high fat diet. Inhibition
of triglyceride synthesis does not improve glucose toler-
ance if adipocyte lipid stores are already low.
Methods
Animals
Procedures were conducted in accordance with the Uni-
versity of Buckingham Home Office UK project licence
under the Animals (Scientific Procedures) Act (1986) and
as agreed by the University of Buckingham Ethical Review
Board.
Total area under the glucose tolerance curve in Dgat1+/+ (+/+), Dgat1+/- (+/-) and Dgat1-/-(-/-) mice fed on a chow diet (A) or a  high fat diet (B); and glucose tolerance curves for male (C) and female (D) mice fed on the high fat diet Figure 3
Total area under the glucose tolerance curve in Dgat1+/+ (+/+), Dgat1+/- (+/-) and Dgat1-/-(-/-) mice fed on a chow diet (A) or a 
high fat diet (B); and glucose tolerance curves for male (C) and female (D) mice fed on the high fat diet. Symbols in C and D: 
Dgat1+/+, ● ❍; Dgat1+/-, ▲ ; Dgat1-/-,  ■. Results are means of 12 values, except that there were 6 female Dgat1-/- mice fed 
on the high fat diet. *P < 0.05; **P < 0.01; ***P < 0.001 compared to Dgat1+/+ mice of the same sex.
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Plasma insulin concentrations in Dgat1+/+ (+/+), Dgat1+/- (+/-) and Dgat1-/-(-/-) mice fed on a chow diet (A) or a high fat diet (B)  immediately before administration of glucose in the glucose tolerance tests, and also 30 min after administration of glucose in  the high fat-fed mice (C) Figure 4
Plasma insulin concentrations in Dgat1+/+ (+/+), Dgat1+/- (+/-) and Dgat1-/-(-/-) mice fed on a chow diet (A) or a high fat diet (B) 
immediately before administration of glucose in the glucose tolerance tests, and also 30 min after administration of glucose in 
the high fat-fed mice (C). Results are means of 12 values, except that there were 6 female Dgat1-/- mice fed on the high fat diet. 
* P < 0.05; ** P < 0.01; *** P < 0.001 compared to Dgat1+/+ mice of the same sex.
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Three male Dgat1-/- and three female Dgat1+/- mice back-
crossed onto a C57Bl/6 background for ten generations
(B6.129S4 – Dgat1tm1Far/J) were purchased from Jackson
Laboratories (Bar Harbor, Maine, USA) and a colony was
expanded in our facilities, breeding from male Dgat1-/-
and female Dgat1+/- mice. The method used to delete the
Dgat1  gene has been reported previously [2]. The off-
spring from the breeding of the Dgat1-/- and Dgat1+/- mice
were genotyped between 4 to 5 weeks of age and in order
to generate littermates of all three possible genotypes,
male and female Dgat1+/-  mice were used for further
rounds of breeding to obtain the experimental mice.
Genomic DNA was extracted from tail tip samples and
Dgat1  and  neomycin  genes detected by PCR using the
primers previously described [2]. The presence of both
neomycin and Dgat1 genes indicated heterozygosity.
Protocol
The mice were fed on a standard chow diet that contained
10% fat, 70% carbohydrate and 20% protein by energy
(14.0 kJ/g metabolisable energy; Beekay Feed, B&K Uni-
versal Ltd., Hull, UK), or they were fed on chow until they
were 12 weeks old and then on a sweetened high fat diet
that contained by energy 45% fat, 35% carbohydrate (of
which half was sucrose) and 20% protein (19.3 kJ/g
metabolisable energy; diet code D12451; Research Diets,
New Brunswick, USA). They were housed at 22°C with
lights on from 07.00 to 19.00 h.
There were twelve mice of each sex and genotype (Dgat1+/
+, Dgat1+/- and Dgat1-/-) housed in threes, except that only
six female Dgat1-/- mice were fed on the high fat diet. Food
intake for each cage of mice was measured daily and body
w e i g h t  w a s  m e a s u r e d  w e e k l y  f r o m  t h e  a g e  o f  9  o r  1 3
weeks in the chow or high fat diet experiments, respec-
tively. Energy expenditure was measured at 12 weeks of
age in mice fed on the chow diet. Glucose tolerance tests
were performed at 15 and 24 weeks of age in the chow and
high fat diet experiments respectively. The mice were
killed after a 5-hour fast aged 20 (chow diet) or 30 (high
fat diet) weeks and blood was taken for the measurement
of plasma leptin (Crystal Chem Inc, Chicago, IL). Body
composition was determined by dual energy X-ray
absorptiometry (Lunar PIXImus 2 mouse densitometer
and version 1.46 software; GE Medical, Bedford, UK).
Glucose tolerance
Mice were fasted for 5 h from 09.00 h before administra-
tion of glucose (2 g/kg, i.p. body weight). Blood samples
were taken from the tip of the tail after the topical appli-
cation of a local anaesthetic (lignocaine gel) at 30-minute
intervals. Glucose and insulin were measured as described
previously [21].
Energy expenditure
Energy expenditure was measured over 24 h, beginning at
10.00 h in the mice's home cage by open circuit indirect
calorimetry using the equation of Weir [22]. The volume
of the mouse cages was 23 litres and the flow rate was 0.8
l/min. Such a system has a calculated half-life of 23.5 min
for responding to a step change in energy expenditure
[17]. It is therefore not suitable for instant measurement
of energy expenditure but with the mice undisturbed in
their home cages, it is ideal for measurement of daily
energy expenditure. The energy expenditure of all the
male mice of all the different genotypes was measured in
a single run over 24 h and after recalibration, the energy
expenditure of all the female mice was measured on the
following day.
Data analysis
Results are presented as means ± S.E. They were analysed
by one-way analysis of variance followed by Bonferroni's
post-test for selected comparisons (wild-type mice with
heterozygous or homozygous mutant mice of the same
sex) unless stated otherwise.
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